Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

Lidak reacquires certain rights to Lidakol from BMS

Dec. 2, 1996

Ivermectin approved for use in humans

Dec. 2, 1996

Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity

Dec. 2, 1996

Frog peptides with antimicrobial activity available for licensing

Dec. 2, 1996

Antimicrobial peptide combinations available for licensing

Dec. 2, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

Antimicrobial ranalexin peptides available for licensing

Nov. 28, 1996

New antibacterial agents under study at Bayer

Nov. 28, 1996

FDA approves Amphotec

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...